Categories: News

Sanofi: Information concerning the total number of voting rights and shares – September 2022

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi
a French société anonyme with a registered share capital of 2,534,952,234 €
Registered office : 54, rue La Boétie – 75008 Paris – France
Registered at the Paris Commercial and Companies Registry under number 395 030 844

Date  

Total number of
issued shares

 

Number of real
voting rights
(excluding treasury shares)
Theoretical number of
voting rights
(including treasury shares)*
September 30, 2022 1,267,479,766 1,411,899,228 1,425,326,874

* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.

This information is also available on the internet website of sanofi under « Regulated Information in France »:
https://www.sanofi.com/en/investors/sanofi-share-and-adrs/share-overview/shares-and-voting-rights/

Investor Relations Department
e-mail: investor.relations@sanofi.com

 

 

Attachment

Staff

Recent Posts

Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with Its CT 3500 Imaging Solution

Philips CT 3500, a scalable, adaptable, and durable imaging solution, improves efficiency and care quality,…

16 minutes ago

LG EXPANDS MENTAL HEALTH SUPPORT FOR NCAA FINAL FOUR HOST SCHOOLS WITH NAMI PARTNERSHIP

LG continues its commitment to supporting mental health awareness, providing resources and support for students…

12 hours ago

Scarless MTF Breast Augmentation Performed by Seattle Plastic Surgeon

Dr. Sajan Delivers Natural-Looking Transgender Breast Augmentation Without Chest ScarsSEATTLE, April 05, 2025 (GLOBE NEWSWIRE)…

15 hours ago

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate…

15 hours ago

BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS

"Oscars® of Science" Awards Six $3 Million Prizes GLP-1 Diabetes and Obesity Discovery | Multiple Sclerosis…

1 day ago

Breakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video Competition

Jasmine Eyal, Age 16, of Singapore, Receives Top Honors and $400,000 in Education Prizes for…

1 day ago